Oligosaccharides Modulate Rotavirus-Associated Dysbiosis and TLR Gene Expression in Neonatal Rats

dc.contributor.authorAzagra Boronat, Ignasi
dc.contributor.authorMassot Cladera, Malen
dc.contributor.authorKnipping, K.
dc.contributor.authorvan't Land, B.
dc.contributor.authorTims, S.
dc.contributor.authorStahl, B.
dc.contributor.authorKnol, J.
dc.contributor.authorGarssen, J.
dc.contributor.authorFranch i Masferrer, Àngels
dc.contributor.authorCastell, Margarida
dc.contributor.authorPérez-Cano, Francisco J.
dc.contributor.authorRodríguez Lagunas, María José
dc.date.accessioned2020-05-22T10:19:21Z
dc.date.available2020-05-22T10:19:21Z
dc.date.issued2019-08-11
dc.date.updated2020-05-22T10:19:22Z
dc.description.abstractColonization of the gut in early life can be altered through multiple environmental factors. The present study aimed to investigate the effects of 2'-fucosyllactose (2'-FL), a mixture of short-chain galactooligosaccharides/long-chain fructooligosaccharides (scGOS/lcFOS) 9:1 and their combination (scGOS/lcFOS/2'-FL) on dysbiosis induced during rotavirus (RV) diarrhea in neonatal rats, elucidating crosstalk between bacteria and the immune system. The dietary interventions were administered daily by oral gavage at days 2-8 of life in neonatal Lewis rats. On day 5, RV SA11 was intragastrically delivered to induce infection and diarrhea assessment, microbiota composition, and gene expression of Toll-like receptors (TLRs) in the small intestine were studied. All dietary interventions showed reduction in clinical variables of RV-induced diarrhea. RV infection increased TLR2 expression, whereas 2'-FL boosted TLR5 and TLR7 expressions and scGOS/lcFOS increased that of TLR9. RV-infected rats displayed an intestinal dysbiosis that was effectively prevented by the dietary interventions, and consequently, their microbiota was more similar to microbiota of the noninfected groups. The preventive effect of 2'-FL, scGOS/lcFOS, and their combination on dysbiosis associated to RV diarrhea in rats could be due to changes in the crosstalk between gut microbiota and the innate immune system.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec691285
dc.identifier.issn2073-4409
dc.identifier.pmid31405262
dc.identifier.urihttps://hdl.handle.net/2445/161990
dc.language.isoeng
dc.publisherMDPI
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/cells8080876
dc.relation.ispartofCells, 2019, vol. 8, num. 8, p. E876
dc.relation.urihttps://doi.org/10.3390/cells8080876
dc.rightscc-by (c) Azagra Boronat, Ignasi et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)
dc.subject.classificationFarmacologia
dc.subject.classificationMicrobiologia
dc.subject.classificationEfectes secundaris dels medicaments
dc.subject.classificationMicrobiota
dc.subject.classificationMicrobiota intestinal
dc.subject.classificationOligosacàrids
dc.subject.classificationRates
dc.subject.classificationCries d'animals
dc.subject.otherPharmacology
dc.subject.otherMicrobiology
dc.subject.otherDrug side effects
dc.subject.otherMicrobiota
dc.subject.otherGastrointestinal microbiome
dc.subject.otherOligosaccharides
dc.subject.otherRats
dc.subject.otherYoung animals
dc.titleOligosaccharides Modulate Rotavirus-Associated Dysbiosis and TLR Gene Expression in Neonatal Rats
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
691285.pdf
Mida:
1.9 MB
Format:
Adobe Portable Document Format